Concepedia

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly, Keith A.A. Fox, Jonas Oldgren, W. Schuyler Jones, Diana A. Gorog, Václav Durdil, Thomas Viethen, Christoph Neumann,

The Lancet · 2022 · 311 citations · 21 references

DOIFull text

Open access

Concepts

References

21

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Gerhard Hindricks, Tatjana Potpara, Nikolaos Dagres et al. · European Heart Journal · 2020 · 9.9K citations · Full text

, , +17

Apixaban versus Warfarin in Patients with Atrial Fibrillation

Christopher B. Granger, John H. Alexander, John J.V. McMurray et al. · New England Journal of Medicine · 2011 · 8.9K citations · Full text

, , +11

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients

Sam Schulman, Clive Kearon · Journal of Thrombosis and Haemostasis · 2005 · 4.9K citations

, , +12

Worldwide Epidemiology of Atrial Fibrillation

Sumeet S. Chugh, Rasmus Havmoeller, Kumar Narayanan et al. · Circulation · 2013 · 4.5K citations · Full text

, , +17

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Craig T. January, L. Samüel Wann, Joseph S. Alpert et al. · Journal of the American College of Cardiology · 2014 · 3K citations

, , +14